Skip to Content

Miglustat use while Breastfeeding

Drugs containing Miglustat: Zavesca

Medically reviewed by Drugs.com. Last updated on Dec 22, 2020.

Miglustat Levels and Effects while Breastfeeding

Summary of Use during Lactation

No published experience exists with miglustat during breastfeeding. Because of the lack of information and its side effect profile, most sources consider breastfeeding to be contraindicated during maternal miglustat therapy.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Alglucerase, Imiglucerase, Taliglucerase Alfa

Substance Identification

Substance Name

Miglustat

CAS Registry Number

72599-27-0

Drug Class

Breast Feeding

Lactation

Enzyme Inhibitors

Glycoside Hydrolase Inhibitors

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.